Article Text

Download PDFPDF
CASE REPORT
Panuveitis simulating ocular Behçet’s in cases of chronic myelogenous leukaemia in remission
  1. Rohan Chawla,
  2. Koushik Tripathy
  1. Department of Ophthalmology, Dr Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, Delhi, India
  1. Correspondence to Dr Koushik Tripathy, koushiktripathy{at}gmail.com

Summary

We report two patients with chronic myelogenous leukaemia (CML) in remission phase who developed panuveitis simulating Behçet’s disease. A 26-year-old man presented with bilateral panuveitis (hypopyon in the right eye, bilateral anterior segment inflammation, vitritis and retinitis). He was on imatinib for CML which was in remission. He gave a history of recurrent oral ulcers. The panuveitis responded to oral and topical steroids but recurred after the steroids were stopped. His ocular condition again stabilised on restarting oral steroids and azathioprine. The second patient, a 28-year-old man, presented with bilateral anterior segment inflammation, vitritis, exudative retinal detachment and hypopyon in the right eye. He was also on imatinib with the CML being in remission. The uveitis and exudative retinal detachment improved on systemic and topical steroids. The vision of this patient did not improve as optic atrophy ensued. The panuveitis seen in our patients with CML responded favourably to oral steroids/immunosuppressant therapy.

  • ophthalmology
  • retina

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors RC was involved in clinical management of the patients. Both the authors acquired the images, drafted the manuscript and have approved the final version of the manuscript. RC and KT agree to be accountable for the work.

  • Competing interests None declared.

  • Patient consent Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.